Literature DB >> 1374684

Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways.

W J Fantl1, J A Escobedo, G A Martin, C W Turck, M del Rosario, F McCormick, L T Williams.   

Abstract

The receptor for platelet-derived growth factor (PDGF) binds two proteins containing SH2 domains, GTPase activating protein (GAP) and phosphatidylinositol 3-kinase (PI3-kinase). The sites on the receptor that mediate this interaction were identified by using phosphotyrosine-containing peptides representing receptor sequences to block specifically binding of either PI3-kinase or GAP. These results suggested that PI3-kinase binds two phosphotyrosine residues, each located in a 5 aa motif with an essential methionine at the fourth position C-terminal to the tyrosine. Point mutations at these sites caused a selective elimination of PI3-kinase binding and loss of PDGF-stimulated DNA synthesis. Mutation of the binding site for GAP prevented the receptor from associating with or phosphorylating GAP, but had no effect on PI3-kinase binding and little effect on DNA synthesis. Therefore, GAP and PI3-kinase interact with the receptor by binding to different phosphotyrosine-containing sequence motifs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374684     DOI: 10.1016/0092-8674(92)90444-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  162 in total

1.  Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1.

Authors:  K M Kriauciunas; M G Myers; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase.

Authors:  T Simoncini; A Hafezi-Moghadam; D P Brazil; K Ley; W W Chin; J K Liao
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

3.  Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells.

Authors:  Wenying Ren; Stephanie W Watts; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-24       Impact factor: 5.464

4.  Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component.

Authors:  R Liu; J N Livingston
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp.

Authors:  A Kazlauskas; G S Feng; T Pawson; M Valius
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

7.  Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.

Authors:  R B Birge; J E Fajardo; C Reichman; S E Shoelson; Z Songyang; L C Cantley; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.

Authors:  G Payne; S E Shoelson; G D Gish; T Pawson; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells.

Authors:  M Matsuda; Y Hashimoto; K Muroya; H Hasegawa; T Kurata; S Tanaka; S Nakamura; S Hattori
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 10.  Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.

Authors:  M Spaargaren; J R Bischoff; F McCormick
Journal:  Gene Expr       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.